These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
197 related items for PubMed ID: 20074229
1. No mutations in the voltage-gated NaV1.7 sodium channel alpha1 subunit gene SCN9A in familial complex regional pain syndrome. de Rooij AM, Gosso MF, Alsina-Sanchis E, Marinus J, van Hilten JJ, van den Maagdenberg AM. Eur J Neurol; 2010 Jun 01; 17(6):808-14. PubMed ID: 20074229 [Abstract] [Full Text] [Related]
2. Primary erythermalgia as a sodium channelopathy: screening for SCN9A mutations: exclusion of a causal role of SCN10A and SCN11A. Drenth JP, Te Morsche RH, Mansour S, Mortimer PS. Arch Dermatol; 2008 Mar 01; 144(3):320-4. PubMed ID: 18347287 [Abstract] [Full Text] [Related]
3. Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel. Natkunarajah J, Atherton D, Elmslie F, Mansour S, Mortimer P. Clin Exp Dermatol; 2009 Dec 01; 34(8):e640-2. PubMed ID: 19549232 [Abstract] [Full Text] [Related]
4. A Novel SCN9A Mutation (F826Y) in Primary Erythromelalgia Alters the Excitability of Nav1.7. Wu B, Zhang Y, Tang H, Yang M, Long H, Shi G, Tang J, Shi X. Curr Mol Med; 2017 Dec 01; 17(6):450-457. PubMed ID: 28990532 [Abstract] [Full Text] [Related]
5. Role of the sodium channel SCN9A in genetic epilepsy with febrile seizures plus and Dravet syndrome. Mulley JC, Hodgson B, McMahon JM, Iona X, Bellows S, Mullen SA, Farrell K, Mackay M, Sadleir L, Bleasel A, Gill D, Webster R, Wirrell EC, Harbord M, Sisodiya S, Andermann E, Kivity S, Berkovic SF, Scheffer IE, Dibbens LM. Epilepsia; 2013 Sep 01; 54(9):e122-6. PubMed ID: 23895530 [Abstract] [Full Text] [Related]
9. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. Yang Y, Wang Y, Li S, Xu Z, Li H, Ma L, Fan J, Bu D, Liu B, Fan Z, Wu G, Jin J, Ding B, Zhu X, Shen Y. J Med Genet; 2004 Mar 01; 41(3):171-4. PubMed ID: 14985375 [Abstract] [Full Text] [Related]
15. Two novel SCN9A mutations causing insensitivity to pain. Nilsen KB, Nicholas AK, Woods CG, Mellgren SI, Nebuchennykh M, Aasly J. Pain; 2009 May 20; 143(1-2):155-8. PubMed ID: 19304393 [Abstract] [Full Text] [Related]
16. Genetic, electrophysiological, and pathological studies on patients with SCN9A-related pain disorders. Yuan JH, Cheng X, Matsuura E, Higuchi Y, Ando M, Hashiguchi A, Yoshimura A, Nakachi R, Mine J, Taketani T, Maeda K, Kawakami S, Kira R, Tanaka S, Kanai K, Dib-Hajj F, Dib-Hajj SD, Waxman SG, Takashima H. J Peripher Nerv Syst; 2023 Dec 20; 28(4):597-607. PubMed ID: 37555797 [Abstract] [Full Text] [Related]
17. A novel mutation in SCN9A in a child with congenital insensitivity to pain. Shorer Z, Wajsbrot E, Liran TH, Levy J, Parvari R. Pediatr Neurol; 2014 Jan 20; 50(1):73-6. PubMed ID: 24188911 [Abstract] [Full Text] [Related]
18. SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Fertleman CR, Baker MD, Parker KA, Moffatt S, Elmslie FV, Abrahamsen B, Ostman J, Klugbauer N, Wood JN, Gardiner RM, Rees M. Neuron; 2006 Dec 07; 52(5):767-74. PubMed ID: 17145499 [Abstract] [Full Text] [Related]
19. Voltage-gated sodium channels: therapeutic targets for pain. Dib-Hajj SD, Black JA, Waxman SG. Pain Med; 2009 Oct 07; 10(7):1260-9. PubMed ID: 19818036 [Abstract] [Full Text] [Related]
20. Congenital insensitivity to pain: novel SCN9A missense and in-frame deletion mutations. Cox JJ, Sheynin J, Shorer Z, Reimann F, Nicholas AK, Zubovic L, Baralle M, Wraige E, Manor E, Levy J, Woods CG, Parvari R. Hum Mutat; 2010 Sep 07; 31(9):E1670-86. PubMed ID: 20635406 [Abstract] [Full Text] [Related] Page: [Next] [New Search]